Clinical trial

Memantine - Communication Study

NCT00624026

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-11-01

PhasePHASE3

Study timeline

Study start (unknown)2007-11-01Date precision: month

Registry last updated2011-11-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

Memantine-HClDRUG

Sponsors & collaborators

Merz Pharmaceuticals GmbHlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00624026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.